BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,353,496 | 0.0% | 29,708 | 0.0% | 0.03% | 0.0% |
| Q2 2023 | $1,353,496 | +12.3% | 29,708 | 0.0% | 0.03% | -3.4% |
| Q1 2023 | $1,204,956 | -19.1% | 29,708 | +1.7% | 0.03% | -21.6% |
| Q4 2022 | $1,488,732 | -5.1% | 29,208 | +0.3% | 0.04% | -14.0% |
| Q3 2022 | $1,568,000 | -32.7% | 29,108 | -19.7% | 0.04% | -28.3% |
| Q2 2022 | $2,330,000 | -20.4% | 36,271 | -3.9% | 0.06% | -4.8% |
| Q1 2022 | $2,927,000 | +2.0% | 37,745 | +12.9% | 0.06% | +6.8% |
| Q4 2021 | $2,869,000 | +14.0% | 33,424 | +6.8% | 0.06% | 0.0% |
| Q3 2021 | $2,517,000 | -49.9% | 31,299 | -49.8% | 0.06% | -49.6% |
| Q2 2021 | $5,019,000 | +26.5% | 62,343 | +32.5% | 0.12% | +17.0% |
| Q1 2021 | $3,967,000 | -20.8% | 47,036 | -24.7% | 0.10% | -24.2% |
| Q4 2020 | $5,010,000 | -0.2% | 62,436 | 0.0% | 0.13% | -10.2% |
| Q3 2020 | $5,021,000 | -1.9% | 62,436 | -1.0% | 0.15% | -28.3% |
| Q1 2020 | $5,118,000 | -1.5% | 63,036 | +1.4% | 0.20% | +28.1% |
| Q4 2019 | $5,198,000 | -4.3% | 62,157 | +0.1% | 0.16% | -11.6% |
| Q3 2019 | $5,431,000 | +6.8% | 62,086 | -0.0% | 0.18% | +7.7% |
| Q2 2019 | $5,087,000 | +2.4% | 62,111 | +1.6% | 0.17% | -2.9% |
| Q1 2019 | $4,969,000 | +23.5% | 61,111 | 0.0% | 0.17% | +6.8% |
| Q4 2018 | $4,022,000 | -10.2% | 61,111 | +5.2% | 0.16% | +6.6% |
| Q3 2018 | $4,478,000 | +6.2% | 58,083 | +1.8% | 0.15% | +0.7% |
| Q2 2018 | $4,215,000 | +16.9% | 57,083 | +3.0% | 0.15% | +10.2% |
| Q1 2018 | $3,606,000 | +9.1% | 55,445 | +8.4% | 0.14% | +14.2% |
| Q4 2017 | $3,306,000 | +4.2% | 51,150 | +1.2% | 0.12% | -0.8% |
| Q3 2017 | $3,172,000 | +5.3% | 50,550 | +1.6% | 0.12% | +0.8% |
| Q2 2017 | $3,013,000 | +17.9% | 49,775 | +1.0% | 0.12% | +16.5% |
| Q1 2017 | $2,555,000 | +16.8% | 49,275 | -0.1% | 0.10% | +10.8% |
| Q4 2016 | $2,188,000 | +20.8% | 49,337 | +29.7% | 0.09% | +17.7% |
| Q3 2016 | $1,811,000 | +12.3% | 38,037 | +6.7% | 0.08% | +9.7% |
| Q2 2016 | $1,612,000 | +71.1% | 35,637 | +55.5% | 0.07% | +63.6% |
| Q1 2016 | $942,000 | +5.5% | 22,920 | -2.1% | 0.04% | +7.3% |
| Q4 2015 | $893,000 | +6.6% | 23,420 | -8.2% | 0.04% | 0.0% |
| Q3 2015 | $838,000 | -57.3% | 25,516 | -9.0% | 0.04% | -53.9% |
| Q2 2015 | $1,961,000 | -12.9% | 28,041 | -14.7% | 0.09% | -13.6% |
| Q1 2015 | $2,252,000 | -14.8% | 32,869 | -8.9% | 0.10% | -16.9% |
| Q4 2014 | $2,643,000 | +3.7% | 36,066 | +1.5% | 0.12% | +2.5% |
| Q3 2014 | $2,549,000 | +39.7% | 35,517 | +40.7% | 0.12% | +36.0% |
| Q2 2014 | $1,825,000 | -1.4% | 25,242 | +0.3% | 0.09% | -7.3% |
| Q1 2014 | $1,851,000 | +15.9% | 25,156 | +9.5% | 0.10% | +12.9% |
| Q4 2013 | $1,597,000 | +7.4% | 22,968 | +1.4% | 0.08% | -2.3% |
| Q3 2013 | $1,487,000 | -5.1% | 22,640 | +0.1% | 0.09% | -10.3% |
| Q2 2013 | $1,567,000 | – | 22,618 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |